![Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells | EMBO Molecular Medicine Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/875b8032-3fd9-440b-bc3e-62e518fde962/emmm202012409-fig-0005-m.jpg)
Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells | EMBO Molecular Medicine
![Burkhard SUMMER | PhD | Doctor of Philosophy | Ludwig-Maximilians-University of Munich, Munich | LMU | Klinik und Poliklinik für Dermatologie und Allergologie Burkhard SUMMER | PhD | Doctor of Philosophy | Ludwig-Maximilians-University of Munich, Munich | LMU | Klinik und Poliklinik für Dermatologie und Allergologie](https://i1.rgstatic.net/ii/profile.image/272184782356486-1441905317517_Q512/Burkhard-Summer.jpg)
Burkhard SUMMER | PhD | Doctor of Philosophy | Ludwig-Maximilians-University of Munich, Munich | LMU | Klinik und Poliklinik für Dermatologie und Allergologie
![Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells | EMBO Molecular Medicine Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/9677e1f3-2379-4657-ad71-8cd9dbfa843a/emmm202012409-fig-0006-m.jpg)
Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells | EMBO Molecular Medicine
![PDF) Pharmacological profile of JNJ-27141491, a non-competitive and orally active antagonist of the human chemokine receptor CCR2 PDF) Pharmacological profile of JNJ-27141491, a non-competitive and orally active antagonist of the human chemokine receptor CCR2](https://i1.rgstatic.net/publication/5253094_Pharmacological_profile_of_JNJ-27141491_a_non-competitive_and_orally_active_antagonist_of_the_human_chemokine_receptor_CCR2/links/54a3fc8f0cf256bf8bb3167e/largepreview.png)
PDF) Pharmacological profile of JNJ-27141491, a non-competitive and orally active antagonist of the human chemokine receptor CCR2
![Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells | EMBO Molecular Medicine Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/06fa3758-2cbc-4d8f-94b6-b7bfffa4d1d4/emmm202012409-fig-0004ev-m.jpg)